Somatometric and Bioimpedance Parameters in the Assessment of Physical Development in Patients with Esophageal Cancer

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Esophageal cancer is an oncological disease characterized by an extremely unfavorable course and prognosis. The high mortality rate associated with esophageal cancer underscores the importance of preventive screening programs in population and the need to expand the range of known risk factors for this disease. In this context, the study of physical development characteristics in patients with esophageal cancer is of particular interest.

AIM: To investigate somatometric and bioimpedance characteristics of physical development in patients with esophageal cancer.

METHODS: Anthropometric and bioimpedance measurements were conducted in 86 patients diagnosed with esophageal cancer. Body height and weight, shoulder and hip width, waist and hip circumference were measured. Body mass index and the sexual dimorphism index according to J.M. Tanner were calculated. Bioimpedance analysis was performed using the ABC01-036 hardware-software system (Medass, Russia). Body composition and phase angle were assessed. The phase angle of impedance reflects the intensity of metabolic processes in the body and is used as a prognostic indicator in oncological diseases. Statistical processing of the obtained data was performed using descriptive statistics methods. The Shapiro–Francia, Kolmogorov–Smirnov, Kruskal–Wallis, Fisher’s F-test, and Pearson’s chi-square test were used. Differences were considered statistically significant at p < 0.05.

RESULTS: Normal body weight was noted in most women with squamous cell carcinoma of the esophagus and in men with esophageal adenocarcinoma. Among male patients with esophageal cancer, the mesomorphic body type predominated, with a shift toward gynecomorphy (p = 0.001). A mesomorphic somatotype prevailed among female patients (p = 0.001). No statistically significant differences in bioimpedance parameters were found among patients with esophageal cancer depending on somatotype. Decreased phase angle values relative to the reference range established for the Russian population were recorded with equal frequency in patients with esophageal cancer, regardless of disease stage, which allows this parameter to be considered a potential marker of poor prognosis.

CONCLUSION: Body weight deficiency is not typical for patients with esophageal adenocarcinoma. Overall, patients with esophageal cancer tend to exhibit a mesomorphic somatotype, with a shift toward gynecomorphy in men, as well as decreased phase angle values regardless of disease stage.

Full Text

Restricted Access

About the authors

Sergey S. Startsev

Sakhalin Regional Clinical Oncology Center; Pacific State Medical University

Email: sakhstar2010@mail.ru
ORCID iD: 0009-0003-0749-0778
SPIN-code: 6223-7575
Russian Federation, Yuzhno-Sakhalinsk; Vladivostok

Ekaterina A. Gorbunova

Professor Voino-Yasenetsky Krasnoyarsk State Medical University; Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Dispensary

Author for correspondence.
Email: opium-100@yandex.ru
ORCID iD: 0000-0002-5297-5980
SPIN-code: 8525-7253

MD, Cand. Sci. (Medicine)

Russian Federation, Krasnoyarsk; Krasnoyarsk

Anna A. Danilova

Professor Voino-Yasenetsky Krasnoyarsk State Medical University

Email: anya.danilova.02@list.ru
ORCID iD: 0009-0006-1412-8066
SPIN-code: 4287-1951
Russian Federation, Krasnoyarsk

Nadezhda N. Medvedeva

Professor Voino-Yasenetsky Krasnoyarsk State Medical University

Email: medvenad@mail.ru
ORCID iD: 0000-0002-7757-6628
SPIN-code: 6144-1780

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Krasnoyarsk

Ruslan A. Zukov

Professor Voino-Yasenetsky Krasnoyarsk State Medical University; Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Dispensary

Email: zukov_rus@mail.ru
ORCID iD: 0000-0002-7210-3020
SPIN-code: 3632-8415

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Krasnoyarsk; Krasnoyarsk

References

  1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–263. doi: 10.3322/caac.21834 EDN: FRJDQH
  2. Lander S, Lander E, Gibson MK. Esophageal cancer: Overview, risk factors, and reasons for the rise. Curr Gastroenterol Rep. 2023;25(11):275–279. doi: 10.1007/s11894-023-00899-0 EDN: ZCSNMO
  3. Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21(26):7933–7943. doi: 10.3748/wjg.v21.i26.7933
  4. Waters JK, Reznik SI. Update on management of squamous cell esophageal cancer. Curr Oncol Rep. 2022;24(3):375–385. doi: 10.1007/s11912-021-01153-4 EDN: SFHQSO
  5. Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21(4):393–422. doi: 10.6004/jnccn.2023.0019 EDN: WHZQFG
  6. Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2021;18(6):432–443. doi: 10.1038/s41575-021-00419-3 EDN: NPDXUE
  7. Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–1021. doi: 10.1007/s12328-020-01237-x EDN: ASXUOY
  8. Gladilina IA, Tryakin AA, Zakhidova FO, et al. Esophageal cancer: epidemiology, risk factors and diagnostic methods. Journal of oncology: diagnostic radiology and radiotherapy. 2020;3(1):69–76. (In Russ.) doi: 10.37174/2587-7593-2020-3-1-69-76 EDN: DUVSPG
  9. Zyuzyukina AV, Gasymly DDK, Komissarova VA, et al. Anthropometric and topometric characterization of patients with breast cancer. Russian Journal of Oncology. 2021;26(3):77–84. (In Russ.) doi: 10.17816/onco107114 EDN: ISNXQQ
  10. Khusnutdinov RM, Sitdikov AM, Fatkullov IR, et al. Comparative analysis of the functional state of the body of athletes and non-athletes according to anthropometry, morphology and IPC. Scientific notes of the P.F. Lesgaft University. 2023;12(226):208–213. (In Russ.) EDN: WQVFSM
  11. Orlov VA, Razumov AN, Strizhakova OV, Fudin NA. Human health - an “activity-based” approach and quantitative measurement. Journal of new medical technologies, eEdition. 2022;16(5):64–70. (In Russ.) doi: 10.24412/2075-4094-2022-5-2-2 EDN: DEGMAA
  12. Sakibaev KSh, Nikityuk DB, Nikolaev DV, et al. Experience in the use of bioimpedance measurement to assess the composition of the human body. Bulletin of Medicine and Education. 2021;(2):137–146. (In Russ.) EDN: FIXXIU
  13. Kostyuchenko LN, Kruglov AD, Kostyuchenko MV, Lychkova AE. Method of bioimpedancemetria for assessing metabolism in colorectal cancer and pancreatic cancer. Medical Alphabet. 2019;4(38):54–58. (In Russ.) doi: 10.33667/2078-5631-2019-4-38(413)-54-58 EDN: UVYLFM
  14. Kamalova AA, Safina ER, Gaifutdinova AR. Body composition in children with inflammatory bowel diseases. Practical medicine. 2022;20(1):67–73. (In Russ.) doi: 10.32000/2072-1757-2022-1-67-73 EDN: WYPJES
  15. Zharikov YuO, Kovaleva ON, Maslennikov RV, Gadzhiakhmedova AN. Nutritional status of patients with cirrhosis of the liver. Chronos. 2022;7(11(73)):30–32. (In Russ.) doi: 10.52013/2658-7556-73-11-8 EDN: SDTULQ
  16. Rudnev SG, Soboleva NP, Sterlikov SA. Bioimpedance study of the body composition in the Russian population. Moscow: Federal Research Institute for Health Care Organization and Information; 2014. (In Russ.) ISBN: 5-94116-018-6 EDN: TDSYFP
  17. Hui D, Moore J, Park M, et al. Phase angle and the diagnosis of impending death in patients with advanced cancer: Preliminary findings. Oncologist. 2019;24(6):e365–e373. doi: 10.1634/theoncologist.2018-0288
  18. Miura T, Matsumoto Y, Kawaguchi T, et al. Low phase angle is correlated with worse general condition in patients with advanced cancer. Nutr Cancer. 2019;71(1):83–88. doi: 10.1080/01635581.2018.1557216
  19. Koyanagi YN, Matsuo K, Ito H, et al. Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population-based cohort studies in Japan. Cancer Sci. 2023;114(7):2961–2972. doi: 10.1111/cas.15805 EDN: EYZUSN
  20. Loehrer EA, Giovannucci EL, Betensky RA, et al. Prediagnostic adult body mass index change and esophageal adenocarcinoma survival. Cancer Med. 2020;9(10):3613–3622. doi: 10.1002/cam4.3015 EDN: ZHZJBK
  21. Li S, Xie K, Xiao X, et al. Correlation between sarcopenia and esophageal cancer: a narrative review. World J Surg Oncol. 2024;22(1):27. doi: 10.1186/s12957-024-03304-w EDN: DEIGGP
  22. Jogiat UM, Bédard ELR, Sasewich H, et al. Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(6):2630–2636. doi: 10.1002/jcsm.13082 EDN: GAERDW
  23. Boshier PR, Heneghan R, Markar SR, et al. Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2018;31(8). doi: 10.1093/dote/doy047
  24. Tanner JM. Childhood epidemiology. Physical development. Br Med Bull. 1986;42(2):131–138. doi: 10.1093/oxfordjournals.bmb.a072110 EDN: ILSADT
  25. Sindeyeva LV, Rudnev SG. Characteristic of the age and sex-reated variability of the Heath-Carter somatotype in adults and possibility of its bioimpedance assessment (as exemplified by Russian population of Eastern Siberia). Morphology. 2017;151(1):77–87 (In Russ.) EDN: YKUYXN
  26. van der Schaaf MK, Tilanus HW, van Lanschot JJ, et al. The influence of preoperative weight loss on the postoperative course after esophageal cancer resection. J Thorac Cardiovasc Surg. 2014;147(1):490–495. doi: 10.1016/j.jtcvs.2013.07.072
  27. Gu WS, Fang WZ, Liu CY, Pan KY, Ding R, Li XH, Duan CH. Prognostic significance of combined pretreatment body mass index (BMI) and BMI loss in patients with esophageal cancer. Cancer Manag Res. 2019;11:3029–3041. doi: 10.2147/CMAR.S197820

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Male patients — frequency of major somatotypes according to J.M. Tanner; SDI — sexual dimorphism index.

Download (158KB)
3. Fig. 2. Female patients — frequency of somatotypes according to J.M. Tanner; SDI — sexual dimorphism index.

Download (160KB)

Copyright (c) 2025 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07

Периодический печатный журнал зарегистрирован как СМИ Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор): 0110212 от 08.02.1993.
Сетевое издание зарегистрировано как СМИ Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор): ЭЛ № ФС 77 - 84733 от 10.02.2023.